Please login to the form below

Not currently logged in
Email:
Password:

migraines

This page shows the latest migraines news and features for those working in and with pharma, biotech and healthcare.

Novartis follows Pfizer and freezes US prices this year

Novartis follows Pfizer and freezes US prices this year

for diffuse large B-cell lymphoma (DLBCL) and new migraine therapy Aimovig (erenumab).

Latest news

More from news
Approximately 18 fully matching, plus 126 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    III CGRP antibody for the treatment of migraine.

  • The good, the bad and the ugly The good, the bad and the ugly

    Three CGRP monoclonal antibodies will launch in the US for migraine in 2018 - with a fourth anticipated in 2019.

  • The cultural construction of illness The cultural construction of illness

    Some years ago, we were asked to advise on marketing a cure for migraines in the UK. ... In this world, migraines were associated with ideas of the overly sensitive, or even hysterical woman, requiring rational male intervention to bring her back to her

  • Ditch the data? Ditch the data?

    Around one in seven people suffer from migraines, and these can impact severely on quality-of-life. ... When a migraine hits, she needs to shut herself in a dark room in silence.

  • Deal Watch January 2017 Deal Watch January 2017

    1, 000. CoLucid. Lilly. Company acquisition. Lasmiditan for the acute treatment of migraine.

More from intelligence
Approximately 2 fully matching, plus 21 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Hanson Zandi

    Migraine. Monoclonal antibodies. Respiratory. Women’s Health.

  • Double Communiqué award win for 90TEN

    The Migraine Unlocked campaign took a surround-sound communications approach using advertising, media and grassroots campaigning to maximise exposure to sufferers and their loved ones. ... Commenting on Migraine Unlocked, t he Comm uniqué judges said:

  • What it takes to win at Cannes Health Lions

    As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for  Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’ s

  • 90TEN nominated for five Communique Awards including Small Consultancy of the Year

    The Allergan “ Migraine Unlocked” campaign is a finalist in Excellence in Communications via a Live Event or Stand-Alone Activity, and an HCV programme for AbbVie has been recognised in the

  • What it takes to win at Cannes Health Lions

    As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for  Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’ s

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics